Barrett's Esophagus

Barrett's Esophagus: Emerging Evidence for Improved Clinical Practice is a comprehensive reference on the treatment and new imaging modalities of Barrett's Esophagus for researchers, clinicians, and scholars. Each chapter is composed from the perspective of investigators who summarize the data as well as the reasoning behind why those studies were conceived. In addition, the future directions of research are discussed within each chapter, providing insights from the investigators. Research questions are described, and cutting-edge applications are explained. Each chapter contains clinical scenarios to highlight the directions in which the research is, and should be, heading. - Provides a perspective into the research behind Barrett's Esophagus - Emphasizes the emerging technologies in surveillance and treatment of Barrett's - Features clinical scenarios to highlight the directions in which research is, and should be, heading - Includes coverage of current guidelines and discussions on where these guidelines fall short

Dr. Pleskow's major research interests have been the study of serologic markers in pancreatic disease, therapeutic pancreaticobiliary endoscopy and endoscopic ultrasound. He pioneered the endoscopic placement of gold markers in patients with pancreaticobiliary malignancy to facilitate Cyberknife therapy. He and his colleagues have worked closely on the endoscopic treatment of Gastroesophageal Reflux Disease (GERD) and Barrett's esophagus. Dr. Pleskow is also an active and influential member of the NPF (National Pancreas Foundation) board and its Executive Committee. He has also previously served as Executive Director and currently presides over the Scientific Advisory Committee and sits on the Grant Review Council. Dr. Pleskow holds board certification from the American Board of Internal Medicine (Gastroenterology).